doi: 10.1172/jci.insight.134270 109 DolletLZierathJR
Among GLP-1 users, the 18-month risk of ION was about 8.5 cases per 10,000 people, compared with 5.5 cases per 10,000 among patients taking SGLT2 inhibitors
It may also help you feel less hungry and burn more calories
Noom Launches Free Version of Its Powerful GLP-1 Companion Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for good PRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider